Our website is not optimised for the browser you are using. You can access all content, however the site may not appear as intended. We therefore recommend using a current version of Microsoft Internet Explorer or Mozilla.
Brenntag is not aware of the composition of the implant filling called the "PIP mix" in the media. It is still unclear to this day to what extent the products delivered by Brenntag have been at all used in the implants.
Today Brenntag, the global market leader in chemical distribution, has announced the acquisition of Amco Internacional S.A. de C.V., a specialty chemical distributor headquartered in Mexico City, Mexico.
Brachem Acquisition S.C.A., the major shareholder of Brenntag AG, announced today that it placed 4.5 million shares of Brenntag AG for a price of EUR 70.00 per share with institutional investors in an accelerated bookbuilding process. Accordingly, the free float increases from close to 64 percent to nearly 73 percent.
Further to recent disclosures and comments regarding the products used in breast implants by French company Poly Implant Prothèse (PIP) and Brenntag’s position as former supplier for PIP, Brenntag provides further information as follows:
Brenntag Specialties Europe is pleased to announce that Colonial Chemical Inc. named them sole distributor in Germany, Switzerland, Austria, Sweden, Denmark, Norway and Finland.
Brenntag Specialties is committed to a collaborative culture whereby our extensive network of market-dedicated experts work in partnership with our customers and suppliers to generate mutually profitable growth.